91Ë¿¹ÏÊÓÆµ

AMR news page with globe on background and headlines from around the world

AMR Centre newsletter
For the latest in
AMR news & events

AMR Centre News


From discovery to solutions: 91Ë¿¹ÏÊÓÆµâ€™s multidisciplinary and collaborative approach to combating antimicrobial resistance

Innovation News Network | 19 December 2025

91Ë¿¹ÏÊÓÆµâ€™s Antimicrobial Resistance (AMR) Centre unites diagnostics, surveillance and prevention, and therapeutics research to deliver real-world solutions against AMR.


Résistance aux antibiotiquesÌýLes bactéries contrattaquent

La Press | 5 December 2025

Fin septembre, le gouvernement fédéral a réévalué les superbactéries les plus inquiétantes, pour la première fois depuis 2015. Cette révision était d’autant plus nécessaire que les infections sont en forte hausse en raison de la résistance accrue aux antibiotiques.


GRAM invites researchers to explore AMR data in repository

University of Oxford | 13 November 2025

AMR data repository contains datasets covering nearly 70 countries and 250,000 patients.


Montreal medical experts address rising antibiotic resistance

Montreal City News | 18 November 2025

Antimicrobial Resistance (AMR) may not sound familiar, but it is one of the most urgent threats to global health, according to medical experts.


Unique enzymes use never-before-seen mechanism to resist antibiotics

Canadian Light Source | 30 October 2025

91Ë¿¹ÏÊÓÆµ researchers find two enzymes that don't use target mimicry to attack antibiotics.


Fourth edition of the MIF puts spotlight on life science

Entrepreneurial spirit is thriving at 91Ë¿¹ÏÊÓÆµ, as shown by a record-breaking 31 applications to the 91Ë¿¹ÏÊÓÆµ Innovation Fund (MIF) this year.ÌýSince its inception in 2020, the MIF has been a catalyst for cutting-edge innovation, and this year’s cohort marks the most competitive pool of candidates yet.


91Ë¿¹ÏÊÓÆµ AMR Centre: Tackling the global threat of antimicrobial resistance through collaborative and interdisciplinary research

Innovation News Network | 21 November 2024

The 91Ë¿¹ÏÊÓÆµ Antimicrobial Resistance Centre emphasizes the urgency of reducing the global threat of AMR and highlights some of the Centre’s key work in this area.


Fighting a silent pandemic: The urgent threat of Antimicrobial Resistance

The Tribune | 19 November 2024

On the brink of a silent pandemic—one where currently treatable infections risk becoming once again life-threatening, institutionsÌýare taking steps to address this challenge.Ìý


91Ë¿¹ÏÊÓÆµ Innovation Fund launches 4th editionÌýwith major support from Desjardins

North America’s largest co-operative financial group to contribute $500,000 for entrepreneurial competition’s top-tier awards

91Ë¿¹ÏÊÓÆµ and Desjardins Group are teaming up to support research-based innovation. North America’s largest co-operative financial group will provide the 91Ë¿¹ÏÊÓÆµ Innovation Fund (MIF) – the biggest entrepreneurial competition at 91Ë¿¹ÏÊÓÆµ – with $500,000 over five years.


Four new clinical trials grants from the CIHR for RI-MUHC researchersÌý

The Government of Canada announced investments in 14 new clinical trials to support Canada’s response to major health threats and bolster the life sciences sector

One of the funded clinical trials includes Centre memberÌý: Biomarker-signature Supported Antibiotic Treatment Decisions in ICU (BAST-ICU).Ìý


Antibiotic-Free Treatment for Infection? New Technology with Potential in the Fight Against Antimicrobial Resistance

microbesNew treatment under development by Professor Karine Auclair and Assistant Professor Andréanne Lupien could potentially treat intracellular infections without the need for traditional antibiotics. Supported by the 91Ë¿¹ÏÊÓÆµ Innovation Fund (MIF) and the 91Ë¿¹ÏÊÓÆµ Antimicrobial Resistance (AMR) Centre, the team hopes to bring this technology to the market.Ìý

Read about this developing technology


Five professors honoured as Montreal ambassadorsÌýman holding glass globe award

91Ë¿¹ÏÊÓÆµ is the only organization with multiple Palais des congrès honourees.


Third running of the MIF turns focus to antimicrobial resistance

lab experiment with hands over Petri dish Innovation is alive and well at 91Ë¿¹ÏÊÓÆµ! Six teams chosen from highly competitive field, as previous participants leverage their experience to secure their spot in new cohort.


MIF launches 3rd edition, offers new AMR award

superbug microbe°Õ³ó±ðÌý91Ë¿¹ÏÊÓÆµ Innovation FundÌý(MIF) is returning for a third edition and is partnering with the 91Ë¿¹ÏÊÓÆµ AMR CentreÌýto provide an additional $75,000 in funding to be distributed as a supplemental prize.Ìý


Getting things started at the 91Ë¿¹ÏÊÓÆµ Antimicrobial ResistanceÌýCentre

Profile of Dr Dao NguyenRI-MUHC and 91Ë¿¹ÏÊÓÆµ researchers join forces against a major global threat to human health.ÌýMobilizing in the fight against antimicrobial resistance (AMR), researchers from the Research Institute of the 91Ë¿¹ÏÊÓÆµ Health Centre (RI-MUHC) and 91Ë¿¹ÏÊÓÆµ have launched a new intensive care unit platform for infection research, with scientific seminars and symposia, funding programs and much more.


MI4, Montreal’s powerhouse of infectious disease research, celebrates 5th anniversary

MI4 brings together over 250 researchers and 5,000 staff from a wide range of fields to find new solutions for some of humanity’s deadliest threats: tuberculosis, antimicrobial resistance, COVID-19 and many more. The group also studies immunity and how the immune system can be harnessed to fight infection.ÌýToday, MI4 has set its sights on a new global threat: antimicrobial resistance (AMR).

profile of 5 scientist involved in MI4


91Ë¿¹ÏÊÓÆµ AMR Researcher Andrew Gonzalez Makes the Highly Cited Researchers 2021ÌýList

Biology professor and AMR associate antimicrobial resistance center member Andrew GonzalezAMR memberÌýAndrew Gonzalez was one of 14 91Ë¿¹ÏÊÓÆµ scientists who made the 2021 list of most highly cited researchers.Ìý The list is compiled yearly by Clarivate and includes the top cited authors within their respective fields.


Stamping out superbugs

Diana Kwon | 24 Sep 2021

As the threat of the pandemic begins to fade in some areas, researchers are turning their attention to another imminent crisis: antimicrobial resistance.

Dr Dao Nguyen and Dr Makeda Semret talk about the antibiotic resistance crisis
Image by Image by Owen Egan/Joni Dufour.


91Ë¿¹ÏÊÓÆµ Health Centre Researcher Vivian Loo Receives the 2021 Peggy Lillis Foundation Innovator Award for Her Work With C.difficle

C.difficile bacteria under the microscope.  MUHC researcher Vivian Loo receives an Innovator Award for her research in C.difficile.Clostridioides difficile causes approximately 500 000 infections a year in the United States mostÌýoften developing following antibiotic treatment. As part of the US C.difficile Awareness month the Peggy Lillis Foundation held its virtual gala to raise awareness and recognize significant contributions in the field. One of three awardees was MUHC researcher Vivian Loo who received the Peggy Lillis Foundation Innovator Award.


91Ë¿¹ÏÊÓÆµ Researchers Solve the Largest Protein Crystal Structure Yet

Crystal structure of COA with bound substrateAMR members Albert Berghuis and Martin Schmeing and their teams have recently solved the crystal structure ofÌýtheÌýThermus thermophilusÌýribosome in complex with plazomicin at a resolution ofÌý3.27 Å.Ìý The structure was recently reported in .


Research Offers Insight in the Battle with Antibiotic Resistance

structural details of EreC, an enzyme responsible for macrolide resistance91Ë¿¹ÏÊÓÆµ researcher Albert Berghuis and his team reported structural details of EreC, anÌýenzyme responsible for macrolide resistance.Ìý The structure was published in .


New AntibioticÌýResistance Centre Will Tackle Resistance Crisis

Dr. Dao Nguyen, Clinician-Scientist in the Respiratory Diseases Program at the Research Institute of the MUHCAntibiotic resistance is considered by the WHO to be one of the greatest threats facing mankind.Ìý With the creation of the Antimicrobial Research Centre, 91Ë¿¹ÏÊÓÆµ Researchers will be at the forefront of the battle against antimicrobialÌýresistance in microorganisms.

Ìý

Ìý

Ìý

Back to top